Medline Inc (MDLN)

Medline Inc. is a healthcare equipment and supplies company listed on NASDAQ as common stock. It manufactures and distributes med-surg products for hospitals, surgery centers, physician offices, post-acute facilities, and nursing homes in the United States and abroad. The company operates through two segments: Medline Brand and Supply Chain Solutions. Medline Brand covers products across surgical solutions, front line care, and laboratory and diagnostics, including wound care, gloves, cleaning supplies, surgical trays, gowns, sterile wraps, diagnostic instruments, and point-of-care testing items. Supply Chain Solutions focuses on third-party product procurement and distribution, along with logistics and supply chain optimization services such as consulting, warehouse and technology management, inventory rationalization, and route planning. Founded in 1966, Medline is based in Northfield, Illinois.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-MDLN
$39.55
-0.1% Downside
Fair
$50.92
28.6% Upside
Undervalued
Good
0.0%
August 5, 2026
34.6x
4.6x
1.8x
51.076 B
51.898 B
17.6%
42.2%
4.2
53.6%
103.1%
Valuation • Fair Value

Medline Inc (NASDAQ-MDLN) Fair Value by Valuation Model

Compare the primary fair value estimate for Medline Inc (NASDAQ-MDLN) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$39.55

Estimated downside of 0.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$37.29

Discounted cash flow valuation reference.

Ben Graham Formula Value

$12.68

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$41.81

Comparable-company valuation reference.

Analyst Price Target

$50.92

Analysts imply upside of 28.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Medline Inc (NASDAQ-MDLN) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Medline Inc (NASDAQ-MDLN)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

29.14 B

Current operating scale indicator.

Revenue Forecast

31.07 B

Forward revenue estimate.

EBITDA

3.044 B

Current operating profitability reference.

EBITDA Forecast

3.543 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Medline Inc (NASDAQ-MDLN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Medline Inc (NASDAQ-MDLN)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

4.2

Relatively strong balance-sheet zone.

FCF / Net Income

103.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Medline Inc (NASDAQ-MDLN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Medline Inc (NASDAQ-MDLN)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 5, 2026

Days to Earnings

15

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

53.6%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Medline Inc (NASDAQ-MDLN), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Medline Inc (NASDAQ-MDLN) Stock Forecast & Technical Outlook

Review Medline Inc (NASDAQ-MDLN) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Medline Inc (NASDAQ-MDLN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Medline Inc (NASDAQ-MDLN) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Medline Inc (NASDAQ-MDLN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Medline Inc (NASDAQ-MDLN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Medline Inc (NASDAQ-MDLN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Medline Inc (NASDAQ-MDLN)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Medline Inc (NASDAQ-MDLN) has a Strong Buy consensus, with 16 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 16
Hold 4
Sell 0
FAQ Fast Investor Answers

Medline Inc (NASDAQ-MDLN) Stock FAQ

Quick answers about Medline Inc (NASDAQ-MDLN) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$39.55
Estimated downside 0.1%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$50.92
Implied upside 28.6%
Financial Health
Good
Current financial-health read

The current fair value estimate for Medline Inc (NASDAQ-MDLN) is $39.55. This implies an estimated downside of 0.1% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for Medline Inc (NASDAQ-MDLN) is $50.92. The analyst target implies estimated upside of 28.6%.

The current financial health read for Medline Inc (NASDAQ-MDLN) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Medline Inc (NASDAQ-MDLN) is August 5, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Medline Inc (NASDAQ-MDLN) is 34.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Medline Inc is 51.076 B.

The current enterprise value listed for Medline Inc is 51.898 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Medline Inc is NASDAQ-MDLN, and the stock is listed on NASDAQ.

Medline Inc (NASDAQ-MDLN) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Medline Inc is 17.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Medline Inc is 42.2%. Free float helps investors understand how much of the share base is available for public trading.